Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Graves´ophthalmopathy with Simvastatin (GO-S)

NCT03131726 is registered in ClinicalTrials.gov with Lund University as lead sponsor.

NCT NCT03131726
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03131726 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Graves´ophthalmopathy with Simvastatin (GO-S)
Lead sponsor
Lund University
Phase
Phase 3
Overall status
Recruiting
Start date
January 26, 2018
Completion date
March 30, 2028
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

graves ophthalmopathy, thyroid associated ophthalmopathy, thyroid associated orbitopathy